Bram Goorden
Head
Pharmaceutical
Prometheus Laboratories
United States of America
Biography
Bram Goorden is General Manager, Head of Prometheus Therapeutics (San Diego, CA), a Nestle Health Science (NHSc) company which focuses on developing and commercializing oncology and GI therapies. Before that, he was Vice President, Global Head of Brain Health at NHSc, with offices in Cambridge, MA. Bram originally joined the company in Switzerland in 2013 to help found a new business for the Nestle Group based on novel therapies through research collaborations, alliances and BD&L deals. Bram brings almost 20 years of experience in life sciences, having held global roles of increasing responsibility in general and commercial management with Eli Lilly and UCB Pharma. Bram began his career as a management consultant at Accenture and performed consulting work for biotech clients in areas such as immunology, bone health and oncology. He is Chairman of the Advisory Board for the Virdis Group, active member of the Biopharma Executive Council, and former member of patient advocacy boards as well as the Foundation for Healthcare Marketers. Bram has a BA from the University of Bologna - Italy, an MSc from the University of Antwerp – Belgium in Commercial Engineering, and an eMBA from the Kellogg School of Management from Northwestern University, Evanston, IL - USA. He is also a trained counsel (system psychology).
Research Interest
Pharmaceutical